iCAD to Report First Quarter 2021 Financial Results on Wednesday, April 28
Rhea-AI Summary
iCAD announced the release of its financial results for Q1 2021, scheduled for April 28, 2021, after market close. The company, a leader in medical technology for cancer detection and therapy, will host a conference call at 4:30 PM ET to discuss the results. Investors can join the call via domestic and international numbers or through a webcast link provided in the announcement.
This update is vital for stakeholders monitoring iCAD's performance in the medical technology sector.
Positive
- None.
Negative
- None.
News Market Reaction – ICAD
In the trading session that priced this news, ICAD gained 5.36%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NASHUA, N.H., April 20, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the first quarter ended March 31, 2021, after the market close, and host a conference call at 4:30pm Eastern Time on Wednesday, April 28.
| Wednesday April 28th @ 4:30pm ET | |
| Domestic: | 877-407-0784 |
| International: | 201-689-8560 |
| Conference ID: | 13718927 |
| Webcast: | http://public.viavid.com/index.php?id=144476 |
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Relations:
Jeremy Feffer, LifeSci Advisors
+ 1-212-915-2568
jeremy@lifesciadvisors.com